Close
24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.

Read the full press release published by the ALBA Synchrotron

More news

08/02/2019 Barcelona Synchrotron Park’s #10YearChallenge 01/02/2019 Eurecat, a provider of innovative technologies 25/01/2019 ALBA Synchrotron’s expertise involved in the design of two scientific facilities 18/01/2019 Stradivarius will launch perfumes 11/01/2019 Graphene-based implant developed by IMB and ICN2 on UAB campus records brain activity 03/01/2019 CREAF: 30 years in environmental sciences
5 6 7 8 9 10 11 12 13 14 15